Prof. Ohemeng is the Dean for the Central University School of Pharmacy (Currently on Sabbatical leave). He graduated with a B. Pharm Honours degree from the Kwame Nkrumah University of Science and Technology (KNUST) in 1978. He served as Teaching Assistant at the Pharmaceutical Chemistry Department in 1979 to 1980. He then proceeded to Duquesne University Pittsburgh, Pennsylvania where he obtained his Ph.D. (Medicinal Chemistry) in 1984. Whilst at Duquesne, he was awarded the Duquesne University Faculty Development Fellowship and also served as Teaching/Research Assistant in the Medicinal Chemistry department. Upon completion, he was awarded the Burroughs-Wellcome fellowship from 1984 to 1987 to undertake a post-doctoral appointment in the Chemistry Department, University of North Carolina, Chapel Hill, NC. USA.
Prof. Ohemeng is a leading academic with considerable expertise in pharmaceutical research, university teaching, academic writing, with vast institutional management experience and close association with a number of international pharmaceutical entities. He has over 30 years of experience working with several major drug manufacturers in the United States, rising to the position of Principal Pharmaceutical Scientist, at Johnson & Johnson. Then to a group leader at Bristol Myers and Squibb. Before moving to Ghana, he was the Executive Director of Medicinal Chemistry, Paratek Pharmaceuticals, Boston Ma USA.
Whiles in Ghana he established Equatorial Healthcare Services, a dynamic, science-based company that focuses on household, agricultural and pharmaceutical products which are of relevance to the tropical world.
He has participated in various U.S and International conferences in the industry and has a great deal of familiarity with the various aspects of the drug development/manufacturing business, including current research and development activities. He has up-to-date information on current research and development activities with more than fifty patents and over eighty-five publications and presentations to his credit. He was involved developing three new drugs for Immtech International and Paratek Pharmaceuticals. Both Omadacycline and Sarecycline have been approved for marketing in the in the USA. He and his team were awarded the 2019 Heroes of Chemistry ward in 2019 in San Diego by the American Chemical society for developing both drugs.
He has also served as a reviewer for several peer reviewed Medicinal Chemistry Journals, such as Bioorganic and Medicinal Chemistry Letters, Bioorganic and Medicinal Chemistry, Journal of Medicinal Chemistry and on the Editorial Board of Emerging Drugs.
Prof Ohemeng also has professional affiliations with the America Chemical Society (Divisions of Organic and Medicinal Chemistry), American Association for the Advancement of Science and the Ghana Pharmaceutical Society. He is a fellow of the Ghana college of Pharmacy.
Contact Details: